-- 泰雷茲集團(HO.PA)重申了其2026年的所有財務目標。受中東持續衝突的影響,該公司今年前三個月的國防業務訂單量大幅成長。 這家總部位於法國的航空航太和國防集團週二公佈,第一季總銷售額年增至53.2億歐元,高於去年同期的49.6億歐元,也高於FactSet匯總的52.3億歐元的普遍預期。其中,國防和航空航太業務分別貢獻了30.5億歐元和13.8億歐元的銷售額,而網路和數位部門的銷售額為8.59億歐元。 同期總訂單量也從37.8億歐元增至46.5億歐元,這主要得益於集團國防業務訂單量75%的內生成長,達到22.4億歐元。航空航太業務的訂單量有機成長1%,達到15.2億歐元,而網路和數位業務的訂單量則下降1%,至8.57億歐元。 從地理來看,成熟市場的訂單量有機成長31%,這主要得益於法國和歐洲其他地區兩位數的有機成長。新興市場的訂單量也有機成長10%,其中近東和中東地區的訂單量有機成長尤為顯著,達185%。 貝倫貝格銀行的分析師在一份簡報中指出:「泰雷茲今天上午發布的2026年第一季業績顯示,國防業務表現強勁,但網絡安全業務表現疲軟,抵消了部分增長。集團收入有機增長9.7%,高於公司此前6-7%的有機增長預期,這主要得益於國防業務14.3%的增長。 泰雷茲集團繼續預計2026年全年有機銷售額將成長6%至7%,相當於年銷售額在233億歐元至236億歐元之間。 「集團業務的基本面穩健,結構性利好趨勢為其成長前景提供了清晰的指引。此外,泰雷茲集團將繼續密切關注全球地緣政治局勢的演變及其潛在的中短期影響。」該公司在一份聲明中表示。 截至週二中午,該集團股票在巴黎下跌近4%。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.